Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.

Matteo MombelliDionysios NeofytosUyen Huynh-DoJavier Sánchez-CéspedesSusanne StampfDela GolshayanSuzan DahdalGuido StirnimannAurelia SchnyderChristian GarzoniReto M VenzinLorenzo MagentaMelanie SchönenbergerLaura WaltiCédric HirzelAline MuntingMichael DickenmannMichael KollerJohn-David AubertJürg SteigerManuel PascualThomas F MuellerMacé SchuurmansChristoph BergerIsabelle BinetJean VillardNicolas J MuellerAdrian EgliElisa CorderoChristian van DeldenOriol Manuelnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

Clinicaltrials.gov NCT03699839.

Keyphrases

high dose
low dose
stem cell transplantation
phase iii
study protocol
phase ii
clinical trial
randomized controlled trial
open label